Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.490
+0.110 (4.62%)
At close: Aug 22, 2025, 4:00 PM
2.450
-0.040 (-1.61%)
After-hours: Aug 22, 2025, 4:03 PM EDT
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $7.98 million as of August 22, 2025. Its market cap has decreased by -3.30% in one year.
Market Cap
7.98M
Enterprise Value
4.97M
1-Year Change
-3.30%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $7.98M, a decrease of -95.87%. That is a compound annual growth rate of -39.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 7.98M | -2.13% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | 103.92M | 39.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 633.30B |
| Johnson & Johnson | 430.71B |
| AbbVie | 369.48B |
| UnitedHealth Group | 271.56B |
| AstraZeneca | 250.11B |
| Novartis AG | 246.48B |
| Novo Nordisk | 239.90B |
| Abbott Laboratories | 230.51B |